Clinical Trials Directory

Trials / Terminated

TerminatedNCT06135051

Ultrasonic Neuromodulation for Treatment of Cognitive Impairment

Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Cognitive Impairment

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate a new form of non-invasive deep brain therapy for individuals with Alzheimer's disease. Low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychophysical and physiological monitoring. A well-tolerated stimulation protocol will be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial. The trial will evaluate brain target engagement using magnetic resonance imaging, PET imaging, and numerical scales of cognitive performance.

Conditions

Interventions

TypeNameDescription
DEVICEDiadem prototypeThe device delivers low-intensity ultrasonic waves into specific brain targets.

Timeline

Start date
2024-08-18
Primary completion
2024-08-21
Completion
2024-08-21
First posted
2023-11-18
Last updated
2025-05-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06135051. Inclusion in this directory is not an endorsement.

Ultrasonic Neuromodulation for Treatment of Cognitive Impairment (NCT06135051) · Clinical Trials Directory